Sermorelin ODT
The current catalog lists compounded oral dissolving sermorelin, subject to clinician assessment and eligibility.
Provider source ↗Virtual provider · Telehealth available
Provider overview
ACT 2 Health publishes a fully online, membership-led care model for adults, with biomarker review and treatment planning overseen by licensed physicians. Its current physician page names Benjamin H. Krasne, MD, Johnathan Chance Miller, MD, and Vanessa Niles, RN, MD, FACOG. The platform reports availability in all 50 states and publishes a 33-item catalog spanning compounded sermorelin, GLP-1-related weight management, men's and women's hormone care, laboratory testing, sexual wellness, and cellular-health services. ACT 2 Health states that it is a technology and administrative-services platform, while medical services are furnished through an independent professional entity and prescriptions may be dispensed by licensed pharmacies, including compounding pharmacies. This unclaimed profile records provider-published information without inferring pharmacy identity, formulation, approval, availability, safety, effectiveness, or individual eligibility.
At a glance
503A and 503B labels describe statutory compounding pathways or public relationships. They do not mean a compounded drug is FDA-approved or that FDA endorses a facility.
Service catalog
Provider-advertised services, grouped for quick scanning with all details visible.
The current catalog lists compounded oral dissolving sermorelin, subject to clinician assessment and eligibility.
Provider source ↗The platform advertises clinician-reviewed compounded injectable and oral semaglutide and tirzepatide options, with eligibility determined during clinical review.
Provider source ↗ACT 2 publishes a monitored testosterone program built from laboratory results, with dosing and delivery selected with a clinician.
Provider source ↗The catalog includes clinician-guided estrogen and progesterone pathways, with testosterone where clinically appropriate.
Provider source ↗Published options include a comprehensive laboratory panel, hormone, gut, methylation, glucose-monitoring, and other specialty testing.
Provider source ↗The platform lists compounded NAD+ injection alongside other clinician-reviewed cellular-health offerings; this profile does not adopt promoted outcomes.
Provider source ↗Oxytocin and a provider-named compounded blend containing tadalafil, oxytocin, and PT-141 appear in the current catalog.
Provider source ↗ACT 2 reports online assessment, clinician review, personalized planning, home delivery when prescribed, and ongoing support in all 50 states.
Provider source ↗Coverage and research
Review every state page this provider advertises serving, then use the related guides to evaluate services and claims.
Continue comparing
Evidence
Logo reproduced from the provider’s official website for identification. Logo source ↗
These links support the public facts recorded here. Provider-published information is not an independent endorsement.
Supports: identity care model services and disclosures · Checked Aug 25, 2026
Supports: physician team · Checked Aug 25, 2026
Supports: treatment catalog and published pricing · Checked Aug 25, 2026
Supports: all 50 states telehealth availability · Checked Aug 25, 2026
Supports: official logo identification source · Checked Aug 25, 2026